Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PediaCare For Older Children, Sudafed Sinus Nighttime Debuting Late Summer

This article was originally published in The Tan Sheet

Executive Summary

Pharmacia is launching two PediaCare line extensions in an attempt to "up-age" the venerable children's cough/cold line, the company said at the National Association of Chain Drug Stores Marketplace 2001 in Las Vegas June 28-July 2.

You may also be interested in...



PediaCare Chewables, New Luden’s Flavors Will Debut In August

Pharmacia is relaunching PediaCare Chewables with new indications and flavoring after discontinuing the brand in 1998, the firm said

PediaCare Chewables, New Luden’s Flavors Will Debut In August

Pharmacia is relaunching PediaCare Chewables with new indications and flavoring after discontinuing the brand in 1998, the firm said

PediaCare Chewables, New Luden’s Flavors Will Debut In August

Pharmacia is relaunching PediaCare Chewables with new indications and flavoring after discontinuing the brand in 1998, the firm said

Related Content

Topics

UsernamePublicRestriction

Register

PS092768

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel